Senior insider sale
President, U.S. Business Unit at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$306.8K
18.32K shares
What this filing means
PACHECO RHONDA JANICE plans to sell 18.32K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $306.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/13/2026ACC: 0001395064-26-000306
Officer· President, U.S. Business Unit
Since Mar 2026
18.32K
Shares to sell
$306.8K
Approx. market value
50.58K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2026
50.58KTotal acquired50.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Restricted Stock Unit Awards - Vested. Compensation | 50.58K | — |
| Total | 50.58K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
18.32K
Market value
$306.8K
7/13/2026
Total
Units
18.32K
Value
$306.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/13/2026 | 18.32K | $306.8K | NYSE | Planned |
| Total | 18.32K | $306.8K | ||